Research groups
Publications
Conference poster
- Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2022). Robust and potent dendritic cells for cancer immunotherapy. (external link)
- Yaping Hua; Yuan Xing; Yunheng Shen et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (external link)
- Yaping Hua; Yuan Xing; Yunheng Shen et al. (2020). Novel STAT3 inhibitors targeting STAT3 dimerization by binding to STAT3 SH2 domain.. (external link)
- Andreas Tvedt Skarstein; Tuyen Hoang; Hallvard Haugen et al. (2023). In vitro Study of STAT3-inhibitors in Drug-Resistant Chronic Myeloid Leukemia (CML). (external link)
- Waqas Azeem; Mohammad Lellahi; Yaping Hua et al. (2023). IDO-1 regulation in human dendritic cells. (external link)
- Yaping Hua; Yuan Xing; Yunheng Shen et al. (2024). Potential of propionyl cinobufagin for the treatment of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC). (external link)
- Yaping Hua; Yuan Xing; Yunheng Shen et al. (2023). Potential of propionyl cinobufagin for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and neuroendocrine prostate cancer (NEPC). (external link)
- Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function. (external link)
- Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2025). Early IDO-1 expression in activated DCs and the positive feedback response to IDO-1 Inhibitors. (external link)
- Yaping Hua; Yuan Xing; Yunheng Shen et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (external link)
- Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy.. (external link)
- Waqas Azeem; Mohammad Lellahi; Yaping Hua et al. (2022). Robust production of potent dendritic cells for cancer immunotherapy. (external link)
- Yi Qu; Run-hui Liu; Jigang Zhang et al. (2013). Reactive oxygen species induce prostate cancer cells via activation of the IL6/STAT3 pathway. Abstract 304. (external link)
- Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2023). Regulation of Indoleamine dioxygenase 1 in human dendritic cells. (external link)
- Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy. (external link)
Academic article
- Yaping Hua; Xing Yuan; Yun-Heng Shen et al. (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. (external link)
- Yaping Hua; Waqas Azeem; Yunheng Shen et al. (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. (external link)
- Waqas Azeem; Jan Roger Olsen; Margrete Reime Hellem et al. (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. (external link)
- Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. (external link)
- Jan Roger Olsen; Waqas Azeem; Margrete Reime Hellem et al. (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. (external link)
- Yi Qu; Anne Margrete Øyan; Run-hui Liu et al. (2013). Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. (external link)
- Waqas Azeem; Margrete Reime Hellem; Jan Roger Olsen et al. (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. (external link)